Court Upholds Pharma Douche’s Ban From Industry

January 24, 2024 Business, Crime

Reuters reports:

Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.

A three-judge panel of the 2nd U.S. Circuit Court of Appeals in Manhattan said a lower court judge acted properly in imposing the ban and ordering Shkreli to repay $64.6 million because of his antitrust violations.

He later served more than four years in prison following his 2017 conviction for defrauding investors in two hedge funds and scheming to defraud investors in another drugmaker.

Read the full article.

Shkreli remains in defiance of the 2022 order to return that $65 million. In 2017, while awaiting sentencing, his bail was revoked after he tweeted an offer of a $5000 bounty for a strand of Hillary Clinton’s hair. 



Tags

© joemygod.com 2024